American Association for the Advancement of Science, Science Translational Medicine, 460(10), 2018
DOI: 10.1126/scitranslmed.aap9128
Full text: Unavailable
A prime and target vaccine for liver-stage malaria results in sterile protection in mouse disease models and appears safe for human use.